New advances in the treatment of hypertrophic obstructive cardiomyopathy
10.3969/j.issn.1004-8812.2024.11.008
- VernacularTitle:梗阻性肥厚型心肌病治疗新进展
- Author:
Ye LIU
1
;
Qiang WU
Author Information
1. 贵州医科大学研究生院,贵州贵阳 550000;贵州省人民医院心血管内科,贵州贵阳 550000
- Keywords:
Hypertrophic cardiomyopathy;
Hypertrophic obstuctive cardiomyopathy;
Pharmacological therapy;
Operative treatment;
Interventional treatment
- From:
Chinese Journal of Interventional Cardiology
2024;32(11):653-657
- CountryChina
- Language:Chinese
-
Abstract:
In the treatment of hypertrophic obstructive cardiomyopathy(HOCM),traditional pharmacotherapy,while palliative for symptoms,fails to target the pathogenic mechanisms to retard the natural progression of the disease,thus exhibiting limitations in management.Although surgical septal myectomy offers definitive therapeutic outcomes,its widespread clinical application is constrained due to the significant invasiveness and elevated risk associated with the procedure.Similarly,the minimally invasive approach of alcohol septal ablation,while a less aggressive treatment option,cannot overlook the potential post-procedural complications such as atrioventricular block.With the continuous advancement of medical technology,treatment strategies for HOCM are evolving.This article aims to provide an overview of the recent advancements in the management of HOCM.
